American Medical Association

SHERPA: White

People

  1. Marghoob
    Marghoob
  2. Halpern
    Halpern
  3. Morrow
    Morrow
  4. Busam
    Busam
  5. Abramson
    Abramson
  6. Brennan
    Brennan
  7. Offit
    Offit
  8. Coit
    Coit
  9. Morris
    Morris
  10. Lee
    Lee

Groups

  1. Department of Medicine (483)
  2. Survivorship Research (357)
  3. Surgery (347)
  4. Population Sciences Research Program (290)
  5. Solid Tumor Oncology Division (233)
  6. Division of Subspecialty Medicine (222)
  7. Epidemiology and Biostatistics (172)
  8. Dermatology (169)
  9. Dermatology Service (168)
  10. Melanoma Disease Management Team (128)
Search Within
Formats
  1. Journal Article (916)
  2. Editorial (89)
  3. Correspondence (56)
  4. Review (39)
  5. Research Letter (37)
  6. Conference Paper (9)
  7. Guidelines (9)
  8. Miscellaneous (6)
Groups
  1. Department of Medicine (483)
  2. Survivorship Research (357)
  3. Surgery (347)
  4. Population Sciences Research Program (290)
  5. Solid Tumor Oncology Division (233)
  6. Division of Subspecialty Medicine (222)

More Groups

People
  1. Ashfaq Marghoob (89)
  2. Allan Halpern (50)
  3. Monica Morrow (46)
  4. Peter Bach (39)
  5. Klaus Busam (35)
  6. David Abramson (33)

More People

Years
  1. 2025 (30)
  2. 2024 (69)
  3. 2023 (63)
  4. 2022 (56)
  5. 2021 (75)
  6. 2020 (72)

More Years

Publications
  1. JAMA Oncology (321)
  2. JAMA - Journal of the American Medical Association (246)
  3. JAMA Dermatology (110)
  4. Archives of Dermatology (86)
  5. JAMA Surgery (77)
  6. Archives of Surgery (73)

More Publications

Results (1161)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Metastatic disease as a distinct discipline in radiation oncology
    Editorial

    Tsai, C. J.; Gomez, D. R.; Yang, T. J.
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Thyroid cancer active surveillance program retention and adherence in Japan
    Journal Article

    Davies, L.; Chang, C. H.; Sirovich, B.; Tuttle, R. M.; Fukushima, M.; Ito, Y.; Miyauchi, A.
    JAMA Otolaryngology - Head and Neck Surgery (2021)

    Fulltext@MSK | Save
  • Association of study methods and industry sponsorship with inconsistent performance of molecular assays for indeterminate thyroid nodules
    Research Letter

    Lee, M.; Valero, C.; Morris, L. G. T.; Marti, J. L.
    JAMA Otolaryngology - Head and Neck Surgery (2021)

    Fulltext@MSK | Save
  • Weight-based dosing of pembrolizumab every 6 weeks in the time of COVID-19
    Editorial

    Goldstein, D. A.; Ratain, M. J.; Saltz, L. B.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Association of coffee intake with survival in patients with advanced or metastatic colorectal cancer
    Journal Article

    Mackintosh, C.; Yuan, C.; Ou, F. S.; Zhang, S.; Niedzwiecki, D.; Chang, I. W.; O'Neil, B. H.; Mullen, B. C.; Lenz, H. J.; Blanke, C. D.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Association between implementation of the 2009 American Thyroid Association Guidelines and de-escalation of treatment for low-risk papillary thyroid carcinoma
    Research Letter

    Lohia, S.; Morris, L. G. T.; Roman, B. R.
    JAMA Otolaryngology - Head and Neck Surgery (2020)

    Fulltext@MSK | Save
  • Indications for total gastrectomy in CDH1 mutation carriers and outcomes of risk-reducing minimally invasive and open gastrectomies
    Journal Article

    Vos, E. L.; Salo-Mullen, E. E.; Tang, L. H.; Schattner, M.; Yoon, S. S.; Gerdes, H.; Markowitz, A. J.; Mandelker, D.; Janjigian, Y.; Offitt, K.; more...
    JAMA Surgery (2020)

    Fulltext@MSK | Save
  • Combination of osimertinib and bevacizumab as first-line treatment for patients with metastatic EGFR-mutant lung cancers - In reply
    Correspondence

    Schoenfeld, A. J.; Yu, H. A.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Important concerns over SARS-CoV-2 infection in children with cancer - Reply
    Correspondence

    Kung, A. L.; Mauguen, A.; Boulad, F.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Early trastuzumab interruption and recurrence-free survival in ERBB2-positive breast cancer
    Research Letter

    Copeland-Halperin, R. S.; Al-Sadawi, M.; Patil, S.; Liu, J. E.; Steingart, R. M.; Dang, C. T.; Yu, A. F.
    JAMA Oncology (2020)

    Fulltext@MSK | Save